Ramipril combained spiranolactone treating Ventricular arrthythmias in congestive heart failure
WU Xiao-chun
Abstract
WU Xiao-chun
Abstract
Objective:To evaluate Ramipril combained spiranolactone's effect on patients from congestive heart failure(CHF) complicated by ventricular arrthythmias.Methods:Patients were treated with Ramipril and spiranolactone. Then observed 24h DCG change for ventricular arrthythmias carefully within 48h in hospital and after 4 weeks' treatment. Results:After 4 weeks' treatment,CHF complicated by ventriclar arrhythmias are obviously reduced. Its pernicious degree drops. Besides,The heart function is improved. Conclusion:Ramipril and spiranolactone have a good effect on treating CHF complicated by ventricular arrthythmias.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate Ramipril combained spiranolactone's effect on patients from congestive heart failure(CHF) complicated by ventricular arrthythmias.Methods:Patients were treated with Ramipril and spiranolactone. Then observed 24h DCG change for ventricular arrthythmias carefully within 48h in hospital and after 4 weeks' treatment. Results:After 4 weeks' treatment,CHF complicated by ventriclar arrhythmias are obviously reduced. Its pernicious degree drops. Besides,The heart function is improved. Conclusion:Ramipril and spiranolactone have a good effect on treating CHF complicated by ventricular arrthythmias.
Key concepts: Medicine, Ramipril, Heart failure, Cardiology, Internal medicine, Ventricular function, Blood pressure